Diabetes mellitus and heart failure: Basic mechanisms, clinical features, and therapeutic considerations

Cardiology Clinics

Volumn 22, Issue 4, 2004, Pages 553-568

  Giles, Thomas D ^a   Sander, Gary E ^a  

^a LOUISIANA STATE UNIV HLTH SCI C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CANDESARTAN; CAPTOPRIL; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; EPLERENONE; FENOFIBRATE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; METOPROLOL; ROSIGLITAZONE; SIMVASTATIN; SULFONYLUREA; THIAZIDE DIURETIC AGENT;

ARTERY INTIMA; ARTERY MEDIA; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; COST BENEFIT ANALYSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; DRUG RESPONSE; DRUG SELECTIVITY; DYSLIPIDEMIA; ECONOMIC ASPECT; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; INTRAVASCULAR ULTRASOUND; ISCHEMIC HEART DISEASE; LONG TERM CARE; METABOLIC SYNDROME X; MICROCIRCULATION; MOLECULAR MECHANICS; PATHOPHYSIOLOGY; PATIENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENESCENCE; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

CARDIOMYOPATHIES; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; RISK FACTORS;

EID: 6344292507     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2004.07.002     Document Type: Review

References (140)

1. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular disease: the Framingham Study JAMA 241 1979 2035 2038
2. D. Kirpichnikov, S.I. McFarlane, and J.R. Sowers Heart failure in diabetic patients: utility of beta-blockade J Card Fail 9 2003 333 344
3. B.M. Massie Obesity and heart failure - risk factor or mechanism? N Engl J Med 347 2002 358 359
4. J.R. Sowers, M. Epstein, and E.D. Frohlich Diabetes, hypertension, and cardiovascular disease: an update Hypertension 37 4 2001 1053 1059
5. I.M. Stratton, A.I. Adler, H.A. Neil, D.R. Matthews, S.E. Manley, and C.A. Cull Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ 321 2000 405 412
6. G.E. Sander, and T.D. Giles Diabetes mellitus and heart failure Am Heart Hosp J 1 2003 273 280
7. L. Amato, G. Paolisso, F. Cacciatore, N. Ferrara, P. Ferrara, and S. Canonico Congestive heart failure predicts the development of non-insulin-dependent diabetes mellitus in the elderly. The Osservatorio Geriatrico Regione Campania Group Diabetes Metab 23 1997 213 218
8. H. Taegtmeter, P. McNulty, and M.E. Young Adaptation and maladaptation of the heart in diabetes: Part I. General concepts Circulation 105 2002 1727 1733
9. T.D. Giles, and G.E. Sander Myocardial disease in hypertensive-diabetic patients Am J Cardiol 87 6A 1989 23S 28S
10. UK Prospective Diabetes Study Group Intensive blood-glucose control with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
11. J.H. Fuller Mortality trends and causes of death in diabetic patients Diabet Metab 38 1993 726 731
12. A. Shehadeh, and T.J. Regan Cardiac consequences of diabetes mellitus Clin Cardiol 18 1995 301 305
13. K. Mizushige, L. Yao, and T. Noma Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model Circulation 101 2000 899 907
14. P. Clarkson, D.S. Celermajer, A.E. Donald, M. Sampson, K.E. Sorensen, and M. Adams Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels J Am Coll Cardiol 28 1996 573 579
15. Y. Yamasaki, R. Kawamori, H. Matsushima, H. Nishizawa, M. Kodama, and Y. Kajimoto Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging Diabetes 43 1994 634 639
16. M.J. Jarvisalo, A. Putto-Laurila, L. Jartti, T. Lehtimaki, T. Solakivi, and T. Ronnemaa Carotid artery intima-media thickness in children with type 1 diabetes Diabetes 51 2002 493 498
17. T. Singh, H. Groehn, and A. Kazmers Vascular function and carotid intimal-medial thickness in children with insulin-dependent diabetes mellitus J Amer Coll Cardiol 41 2003 661 665
18. K.T. Weber, C.G. Brilla, S.E. Campbell, G. Zhou, L. Matsubara, and E. Guarda Pathologic hypertrophy with fibrosis: the structural basis for myocardial failure Blood Press 1 1992 75 85
19. C.G. Brilla, B. Maisch, and K.T. Weber Myocardial collagen matrix remodelling in arterial hypertension Eur Heart J 13 Suppl D 1992 24 32
20. A.J. Coats, and S. Anker Insulin resistance in chronic heart failure J Cardiovasc Pharmacol 35 Suppl 4 2000 S9 S14
21. W. Doehner, S.D. Anker, and A.J. Coats Defects in insulin action in chronic heart failure Diabetes Obes Metab 2 2000 203 212
22. M. Coutinho, H.C. Gerstein, Y. Wang, and S. Yusuf The relationship between glucose and incident cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care 22 1999 233 240
23. C.U. Chae, R.J. Glynn, and J.E. Manson Diabetes predicts congestive heart failure Circulation 98 Suppl I 1998 I658
24. C. Iribarren, A.J. Karter, A.S. Go, A. Ferrara, J.Y. Liu, and S. Sidney Glycemic control and heart failure among adult patients with diabetes Circulation 103 2001 2668 2673
25. N. Suskin, R.S. McKelvie, R.J. Burns, R. Latini, D. Pericak, and J. Probstfield Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure Eur Heart J 21 2000 1368 1375
26. T.D. Giles, J. Ouyang, E.K. Kerut, M.B. Given, G.E. Allen, and E.F. McIlwain Changes in protein kinase C in early cardiomyopathy and in gracilis muscle in the BB/Wor diabetic rat Am J Physiol 274 1Pt2 1998 H295 H307
27. T.D. Giles AngiotensinI-converting enzyme/kinase II dysregulation in cardiovascular complications of diabetes mellitus Giles T.D. Angiotensin converting enzyme. Clinical and experimental insights 2001 Health Care Communications, Inc. Fort Lee, NJ 135 144
28. P. Xia, T. Inoguchi, T.S. Kern, R.L. Engerman, P.J. Oates, and G.L. King Characterization of the mechanism for the chronic activation of diacylglycerol protein kinase C pathway in diabetes and hypergalactosemia Diabetes 43 1994 1122 1129
29. T.S. Lee, K.A. Saltsman, H. Ohashi, and G.L. King Activation of protein kinase C by elevation of glucose concentration: Proposal for a mechanism in the development of diabetic vascular complications Proc Natl Acad Sci USA 86 1989 5141 5145
30. T. Inoguchi, R. Battan, E. Handler, J.R. Sportsman, W. Heath, and G.L. King Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation Proc Natl Acad Sci USA 89 1992 11059 11063
31. Y. Nishizuka Protein kinase C and lipid signaling for sustained cellular responses FASEB J 9 1995 484 496
32. + channels in Xenopus oocytes by protein kinase C FEBS Lett 306 1992 113 118
33. J.P. Liu Protein kinase C and its substrates Mol Cell Endocrinol 116 1996 129
34. +) dependent actomyosin MgATPase activity and troponin T binding to tropomyosin F actin complex Biochem J 288 1992 123 129
35. M. Gautel, O. Zuffardi, A. Freiburg, and S. Labeit Phosphorylation switches specific for the cardiac isoform of myosin binding protein C: a modulator of cardiac contraction? EMBO J 14 1995 1952 1960
36. A. Koj Initiation of acute phase response and synthesis of cytokines Biochim Biophys Acta 1317 1996 84 94
37. C.K. Sen, and L. Packer Antioxidant and redox regulation of gene transcription FASEB J 10 1996 709 720
38. N. Iwai, M. Matsunaga, T. Kita, M. Tei, and C. Kawai Regulation of angiotensin converting enzyme activity in cultured human vascular endothelial cells Biochem Biophys Res Commun 149 1987 1179 1185
39. J. Lieberman, and A. Sastre Serum angiotensin converting enzyme: elevations in diabetes mellitus Ann Intern Med 93 1980 825 826
40. G. Schernthaner, C.H. Schwarzer, R. Kuzmits, M.M. Muller, U. Klemen, and H. Freyler Increased angiotensin converting enzyme activities in diabetes mellitus: analysis of diabetes type, state of metabolic control and occurrence of diabetic vascular disease J Clin Pathol 37 1984 307 312
41. M.J. Troop, K.J.C. Dallinger, P.E. Jennings, and A.H. Barnett Angiotensin converting enzyme (ACE): relationship to insulin dependent diabetes and microangiopathy Diabet Med 3 1986 455 457
42. P.A. Baeuerle, and D. Baltimore NF-kappa B: ten years after Cell 87 1996 13 20
43. Y. Kawahara, M. Sunako, T. Tsuda, H. Fukuzaki, Y. Fukumoto, and Y. Takai Angiotensin II induces expression of the cfos gene through protein kinase c activation and calcium ion mobilization in cultured vascular smooth muscle cells Biochem Biophys Res Commun 150 1988 52 59
44. + homeostasis and formation of cGMP and prostacyclin Am J Physiol 265 1993 C1620 C1629
45. B.N. Finck, J.J. Lehman, T.C. Leone, M.J. Welch, M.J. Bennett, and A. Kovacs The cardiac phenotype induced by PPAR alpha overexpression mimics that caused by diabetes mellitus J Clin Invest 51 2002 2587 2595
46. C. Depre, M.E. Young, J. Ying, H.S. Ahuja, Q. Han, and N. Garza Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction J Mol Cell Cardiol 32 2000 985 996
47. H. Matsui, K. Okumura, H. Mukawa, M. Hibino, Y. Toki, and T. Ito Increased oxysterol contents in diabetic rat hearts: their involvement in diabetic cardiomyopathy Can J Cardiol 13 1997 373 379
48. G.J. Van der Vusse, M. van Bilsen, and J.F. Glatz Cardiac fatty acid uptake and transport in health and disease Cardiovasc Res 45 2000 279 293
49. M.E. Young, F.A. Laws, G.W. Goodwin, and H. Taegtmeyer Reactivation of peroxisome proliferators-activated receptor alpha is associated with contractile dysfunction in hypertrophied rat heart J Biol Chem 276 2001 44390 44395
50. M.C. Sugden, F.A. Orfali, L.G. Fryer, M.J. Holness, and D.A. Priestman Molecular mechanisms underlying the long-term impact of dietary fat to increase cardiac pyruvate dehydrogenase kinase. Regulation by insulin, cyclic AMP and pyruvate J Mol Cell Cardiol 29 1997 1867 1875
51. W.B. Kannel Hazards, risks, and threats of heart disease from the early stages to symptomatic coronary heart disease and cardiac failure Cardiovasc Drug Ther 11 1997 199 212
52. G. Paolisso, S. De Riu, G. Marrazzo, M. Verza, M. Varricchio, and F. D'Onofrio Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure Metabolism 40 1991 972 977
53. G. Paolisso, M.R. Tagliamonte, M.R. Rizzo, A. Gambardella, P. Gualdiero, and D. Lama Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease Am J Cardiol 83 1999 1338 1344
54. J.W. Swan, C. Walton, I.F. Godsland, A.L. Clark, A.J. Coats, and M.F. Oliver Insulin resistance in chronic heart failure Eur Heart J 15 1994 1528 1532
55. J.W. Swan, S.D. Anker, C. Walton, I.F. Godsland, A.L. Clark, and F. Levya Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure J Am Coll Cardiol 30 1997 527 532
56. W. Doehner, C.D. Pflaum, M. Rauchhaus, I.F. Godsland, K. Egerer, and M. Cicoira Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia Eur J Endocrinol 145 2001 727 735
57. W. Parsonage, D. Hetmanski, and A. Cowley Differentiation of the metabolic and vascular effects of insulin in insulin resistance in patients with chronic heart failure Am J Cardiol 89 2002 696 703
58. M.I. Schmidt, B.B. Duncan, A.R. Sharrett, G. Lindberg, P.J. Savage, and S. Offenbacher Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study Lancet 353 1999 1649 1652
59. A.D. Pradhan, J.E. Manson, J.B. Meigs, N. Rifai, J.E. Buring, and S. Liu Insulin, proinsulin, proinsulin:insulin ratio, and the risk of developing type 2 diabetes mellitus in women Am J Med 114 2003 438 444
60. J.B. Meigs, F.B. Hu, N. Rifai, and J.E. Manson Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 2004 1978 1986
61. S.M. Factor, A. Borczuk, M.J. Charron, F.S. Fein, K.H. van Hoeven, and E.H. Sonnenblick Myocardial alterations in diabetes and hypertension Diab Res Clin Practice 31 Suppl 1996 S133 S142
62. M.L. Hockensmith, R.O. Estacio, P. Mehler, E.P. Havranek, S.T. Ecder, and R.A. Lundgren Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes J Card Fail 10 2004 126 131
63. V. Palmieri, J.N. Bella, D.K. Arnett, J.E. Liu, A. Oberman, and M.Y. Schuck Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study Circulation 103 2001 102 107
64. R.M. Jacoby, and R.W. Nesto Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis J Am Coll Cardiol 20 1992 736 744
65. S. Fava, J. Azzopardi, H.A. Muscat, and F.F. Fenech Factors that influence outcome in diabetic subjects with myocardial infarction Diabetes Care 16 1993 1615 1618
66. American Diabetes Association Consensus development conference on the diagnosis of coronary heart disease in people with diabetes Diabetes Care 21 1998 1551 1559
67. A.R. Christlieb Diabetes and hypertensive vascular disease. Mechanisms and treatment Am J Cardiol 32 1973 592 606
68. A.R. Christlieb, A.S. Krolewski, and J.H. Warram Systemic hypertension, diabetes mellitus and the kidney Am J Cardiol 60 1987 61I 65I
69. P.L. Drury Diabetes and arterial hypertension Diabetologia 24 1983 1 9
70. W.C. Knowler, P.H. Bennett, and E.J. Ballintine Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians N Engl J Med 302 1980 645 650
71. G.A. Nichols, T.A. Hillier, J.R. Erbey, and J.B. Brown Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors Diabetes Care 24 2001 1614 1619
72. S. Rubler, J. Dlugash, Y.Z. Yucheoglu, T. Kumral, A.W. Branwood, and A. Grishman New type of cardiomyopathy associated with diabetic glomerulosclerosis Am J Cardiol 30 1972 595 602
73. R.I. Hamby, S. Zoneraich, and L. Sherman Diabetic cardiomyopathy JAMA 229 1974 1749 1754
74. M.I.J. Uusitupa, J.N. Mustonen, and K.E.J. Airaksinen Diabetic heart muscle disease Ann Med 22 1990 377 386
75. S.W. Zarich, and R.W. Nesto Diabetic cardiomyopathy Am Heart J 118 1989 1000 1012
76. R.R. Mildenberger, B. Bar-Schlomo, M.N. Druck, G. Jablonsky, J.E. Morch, and J.D. Hilton Clinically unrecognized ventricular dysfunction in young diabetic patients J Am Coll Cardiol 4 1984 234 238
77. Z. Vered, A. Battler, and P. Segal Exercise-induced left ventricular dysfunction in young men with asymptomatic diabetes mellitus (diabetic cardiomyopathy) Am J Cardiol 54 1984 633 637
78. V.C. Baum, L.L. Levitsky, and R.M. Englander Abnormal cardiac function after exercise in insulin-dependent diabetic children and adolescents Diabetes Care 10 1987 319 323
79. K.M. Borow, J.B. Jaspan, K.A. Williams, A. Neumann, P. Wolinsky-Walley, and R.M. Lang Myocardial mechanics in young adult patients with diabetes mellitus: effects of altered load, inotropic state and dynamic exercise J Am Coll Cardiol 15 1990 1508 1517
80. T.W. Rowland, P.M. Martha Jr., E.O. Reiter, and L.N. Cunningham The influence of diabetes mellitus on cardiovascular function in children and adolescents Int J Sports Med 13 1992 431 435
81. B.N. Campaigne, K.W. Landt, F.W. James, J. Reimar, W. Mays, and M.A. Sperling Systolic time intervals before and after maximal exercise in adolescents with insulin-dependent diabetes mellitus Pediatr Exerc Sci 4 1992 85 93
82. T.R. Kimball, S.R. Daniels, P.R. Khoury, R.A. Magnotti, A.M. Turner, and L.M. Dolan Cardiovascular status in young patients with insulin-dependent diabetes mellitus Circulation 90 1994 357 361
83. B. Linnemann, and H.U. Janka Prolonged QTc interval and elevated heart rate identify the type 2 diabetic patient at high risk for cardiovascular death. The Bremen diabetes study Exp Clin Endocrinol Diabetes 111 2003 215 222
84. J.K. Boyer, S. Thanigaraj, K.B. Schechtman, and J.E. Perez Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus Am J Cardiol 93 2004 870 875
85. J.E. Liu, V. Palmieri, M.J. Roman, J.N. Bella, R. Fabsitz, and B.V. Howard The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study JACC 37 2001 1943 1949
86. S.W. Zarich, B.E. Arbuckle, L.R. Cohen, M. Roberts, and R.W. Nesto Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography J Am Coll Cardiol 12 1988 114 120
87. D.C. Raev Which left ventricular function is impaired earlier in the evolution of diabetic cardiomyopathy? An echocardiographic study of young type I diabetic patients Diabetes Care 17 1994 633 639
88. C. Paillole, M. Dahan, F. Paycha, A.C. Solal, P. Passa, and R. Gourgon Prevalence and significance of left ventricular filling abnormalities determined by Doppler echocardiography in young type I (insulin-dependent) diabetic patients Am J Cardiol 64 1989 1010 1016
89. M. Diamant, H.J. Lamb, Y. Groeneveld, E.L. Endert, J.W.A. Smit, and J.J. Bax Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus J Am Coll Cardiol 42 2003 328 335
90. Z.Y. Fang, S. Yuda, V. Anderson, L. Short, C. Case, and T.H. Marwick Echocardiographic detection of early diabetic myocardial disease J Am Coll Cardiol 41 2003 611 617
91. Z.Y. Fang, O. Najos-Valencia, R. Leano, and T.H. Marwick Patients with early diabetic heart disease demonstrate a normal myocardial response to dobutamine J Am Coll Cardiol 42 2003 446 453
92. E. Picano Diabetic cardiomyopathy: the importance of being earliest J Am Coll Cardiol 42 2003 454 457
93. K.K. Kerut, M.B. Given, E. McIlwain, G. Allen, C. Espinoza, and T.D. Giles Echocardiographic texture analysis using the wavelet transform: differentiation of early heart muscle disease Ultrasound Med Biol 26 2000 1445 1453
94. G. Crepaldi, and R. Nosadini Diabetic cardiopathy: is it a real entity? Diabetes Metab Rev 4 1988 273 288
95. J. Fuller, M.J. Shipley, G. Rose, R.J. Jarrett, and H. Keen Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study Br Med J (Clin Res Ed) 287 1983 867 870
96. A.M. Vihert, V.S. Zhdanov, and E.E. Matova Atherosclerosis of the aorta and coronary vessels of the heart in cases of various diseases J Atheroscler Res 9 1969 179 192
97. I. Stranders, M. Diamant, R.E. van Gelder, H.J. Spruijt, J.W.R. Twisk, and R.J. Heine Admission blood glucose level as a risk indicator of death after myocardial infarction in patients with and without diabetes mellitus Arch Intern Med 164 2004 982 988
98. S.E. Capes, D. Hunt, K. Malmberg, and H.C. Gerstein Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview Lancet 355 2000 773 778
99. R.W. Nesto, R.T. Phillips, K.G. Kett, T. Hill, E. Perper, and E. Young Relationship of angina to ischemia in diabetics and nondiabetics: assessment by exercise thallium scintigraphy Ann Intern Med 108 1988 170 175
100. M.J. Koistinen Prevalence of asymptomatic myocardial ischemia in diabetic subjects BMJ 301 1990 92 95
101. G.E. Sander Diagnostic evaluation for coronary artery disease in the patient with diabetes mellitus T. Giles Diabetes & cardiovascular disease. A practical primer 2000 IPE-LSUHSC New Orleans (LA) 41 64
102. S.U. Pitale, C. Abraira, N.V. Emanuele, M. McCarren, W.G. Henderson, and I. Pacold Two years of intensive glycemic control and left ventricular function in the Veterans Affairs Cooperative Study in Type 2 Diabetes Mellitus (VA CSDM) Diabetes Care 23 2000 1316 1320
103. United Kingdom Prospective Diabetes Study (UKPDS) Group Investigators Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ 317 1998 703 713
104. United Kingdom Prospective Diabetes Study (UKPDS) Group Investigators Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 BMJ 317 1998 713 720
105. T.D. Giles The patient with diabetes mellitus and heart failure: at-risk issues Am J Med 115 Suppl 8A 2003 107S 110S
106. V.A. Fonseca Management of diabetes mellitus and insulin resistance in patients with cardiovascular disease Am J Cardiol 92 4A 2003 50J 60J
107. Prospective Diabetes Study UK. (UKPDS) Group Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) Lancet 352 1998 854 865
108. S.E. Inzucchi Oral antihyperglycemic therapy for type 2 diabetes: scientific review JAMA 287 2002 360 372
109. A.A. Parulkar, M.L. Pendergrass, R. Granda-Ayala, T.R. Lee, and V.A. Fonseca Nonhypoglycemic effects of thiazolidinediones Ann Intern Med 134 2001 61 71
110. M. St John Sutton, M. Rendell, P. Dandona, J.F. Dole, K. Murphy, and R. Patwardhan A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes Diabetes Care 25 2002 2058 2064
111. R.L. Schneider, S.J. Shaffer, and for the Pioglitazone 011 study Group Long-term echocardiographic assessment in patients with type diabetes mellitus treated with pioglitazone (abstract) Diabetes 49 Suppl 1 2000 A124
112. S.M. Haffner, A.S. Greenberg, W.M. Weston, H. Chen, K. Williams, and M.I. Freed Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus Circulation 106 2002 679 684
113. National Diabetes Information Clearinghouse. Diabetes statistics; 2000. Bethesda, National Institutes of Health, Publication #NIH 02-3892.
114. A.I. Adler, I.M. Stratton, H.A. Neil, J.S. Yudkin, D.R. Matthews, and C.A. Cull Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study BMJ 321 2000 412 419
115. L. Hansson, A. Zanchetti, S.G. Carruthers, B. Dahlof, D. Elmfeldt, and S. Julius Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group Lancet 351 1998 1755 1762
116. G.L. Bakris, M. Williams, L. Dworkin, W.J. Elliott, M. Epstein, and R. Toto Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group Am J Kid Dis 36 2000 646 661
117. C. Arauz-Pacheco, M.A. Parrott, and P. Raskin The treatment of hypertension in adult patients with diabetes Diabetes Care 25 2002 134 147
118. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Jr. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572
119. G.L. Bakris The importance of blood pressure control in the patient with diabetes Am J Med 116 2004 30S 38S
120. C.J. Pepine, E.M. Handberg, R.M. Cooper-DeHoff, R.G. Marks, P. Kowey, F.H. Messerli, and for the INVEST Investigators A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA 290 2003 2805 2816
121. Officers ALLHAT and Coordinators for the ALLHAT Collaborative Research Group Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 28 2002 2981 2997
122. L. Golan, J.D. Birkmeyer, and H.G. Welch The cost effectiveness of treating all patients with type 2 diabetes with ACE inhibitors Ann Intern Med 131 1999 600 667
123. G.L. Bakris, and M.R. Weir Achieving blood pressure goal in patients with type-2 diabetes: conventional versus fixed-dose combination approaches J Clin Hypertens 5 2003 202 209
124. R. Collins, J. Armitage, S. Parish, P. Sleigh, and R. Peto Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
125. Diabetes Atherosclerosis Intervention Study Investigators Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study Lancet 357 2001 905 909
126. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease N Engl J Med 335 1996 217 225
127. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status J Am Coll Cardiol 35 2000 1122 1129
128. L. Schwartz, K.E. Kip, R.L. Frye, E.L. Alderman, H.V. Schaff, and K.M. Detre Bypass Angioplasty Revascularization Investigation. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI) Circulation 106 2002 2652 2658
129. J. Kao, J. Tobis, R.L. McClelland, M.R. Heaton, B.R. Davis, and D.R. Holmes Jr. Investigators in the Prevention of Restenosis With Tranilast and Its Outcomes Trial. Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous intervention Am J Cardiol 93 2004 1347 1350
130. J.A. Colwell Aspirin therapy in diabetes Diabetes Care 20 1997 1767 1771
131. P.G. Shekelle, M.W. Rich, S.C. Morton, C.S. Atkinson, W. Tu, and M. Maglione Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials J Am Coll Cardiol 41 2003 1529 1538
132. S. Jacob, K. Rett, M. Wicklmayr, B. Agrawal, H.J. Augustin, and G.J. Dietze Differential effects of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study J Hypertens 14 1996 489 494
133. T. Kubo, E.R. Azevedo, G.E. Newton, J.D. Parker, and J.S. Floras Lack of evidence for peripheral alpha(1)-adrenoceptor blockade during long-term treatment of heart failure with carvedilol J Am Coll Cardiol 38 2001 1463 1469
134. M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, J.J. McMurray, and E.L. Michelson CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme Lancet 362 2003 759 766
135. B. Pitt, W. Remme, F. Zannad, J. Neaton, F. Martinez, and B. Roniker Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
136. J.P. Piccini, L. Klein, M. Gheorghiade, and R.O. Bonow New insights into diastolic heart failure: role of diabetes mellitus Am J Med 116 5A 2004 64S 75S
137. S.I. McFarlane, A. Kumar, and J.R. Sowers Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease Am J Cardiol 91 Suppl 1 2003 30H 37H
138. UKPD Study Group Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39 BMJ 317 1998 713 720
139. P. Gaede, P. Vedel, N. Larsen, G.V. Jensen, H.H. Parving, and O. Pedersen Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes N Engl J Med 348 2003 383 393
140. The CDC Diabetes Cost-effectiveness Group Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes JAMA 287 2002 2542 2551